n-methyl-3,4-methylenedioxyamphetamine has been researched along with Appetite Disorders in 4 studies
N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ninety individuals with severe PTSD received treatment in a double-blind, placebo-controlled pivotal trial of MDMA-AT." | 3.11 | MDMA-assisted therapy significantly reduces eating disorder symptoms in a randomized placebo-controlled trial of adults with severe PTSD. ( Brewerton, TD; Doblin, R; Emerson, A; Lafrance, A; Mithoefer, M; Pamplin, C; Wang, JB; Yazar-Klosinki, B, 2022) |
| "Despite advances in the field, eating disorders (EDs) remain very challenging disorders to treat, especially when comorbid with posttraumatic stress disorder (PTSD)." | 1.62 | The potential use of N-methyl-3,4-methylenedioxyamphetamine (MDMA) assisted psychotherapy in the treatment of eating disorders comorbid with PTSD. ( Brewerton, TD; Lafrance, A; Mithoefer, MC, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brewerton, TD | 2 |
| Wang, JB | 1 |
| Lafrance, A | 2 |
| Pamplin, C | 1 |
| Mithoefer, M | 1 |
| Yazar-Klosinki, B | 1 |
| Emerson, A | 1 |
| Doblin, R | 1 |
| Mithoefer, MC | 1 |
| Compan, V | 1 |
| Charnay, Y | 1 |
| Dusticier, N | 1 |
| Daszuta, A | 1 |
| Hen, R | 1 |
| Bockaert, J | 1 |
| Curran, HV | 1 |
| Robjant, K | 1 |
1 trial available for n-methyl-3,4-methylenedioxyamphetamine and Appetite Disorders
| Article | Year |
|---|---|
MDMA-assisted therapy significantly reduces eating disorder symptoms in a randomized placebo-controlled trial of adults with severe PTSD.
Topics: Adult; Combined Modality Therapy; Double-Blind Method; Feeding and Eating Disorders; Female; Humans; | 2022 |
3 other studies available for n-methyl-3,4-methylenedioxyamphetamine and Appetite Disorders
| Article | Year |
|---|---|
The potential use of N-methyl-3,4-methylenedioxyamphetamine (MDMA) assisted psychotherapy in the treatment of eating disorders comorbid with PTSD.
Topics: Combined Modality Therapy; Feeding and Eating Disorders; Humans; N-Methyl-3,4-methylenedioxyamphetam | 2021 |
[Feeding disorders in 5-HT4 receptor knockout mice].
Topics: Animals; Anorexia; Appetite; Chromatography, High Pressure Liquid; Corticosterone; Feeding and Eatin | 2004 |
Eating attitudes, weight concerns and beliefs about drug effects in women who use ecstasy.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Appetite; Attitude to Health; Body Image; Body Wei | 2006 |